SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-035415
Filing Date
2011-04-14
Accepted
2011-04-13 21:55:18
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c15518e10vk.htm 10-K 598608
2 EXHIBIT 21.1 c15518exv21w1.htm EX-21.1 1486
3 EXHIBIT 23.1 c15518exv23w1.htm EX-23.1 1452
4 EXHIBIT 23.2 c15518exv23w2.htm EX-23.2 1878
5 EXHIBIT 31.1 c15518exv31w1.htm EX-31.1 9568
6 EXHIBIT 31.2 c15518exv31w2.htm EX-31.2 9378
7 EXHIBIT 32.1 c15518exv32w1.htm EX-32.1 4375
  Complete submission text file 0000950123-11-035415.txt   627763
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24274 | Film No.: 11758198
SIC: 2836 Biological Products, (No Diagnostic Substances)